Montelukast Chewable Tablets 5mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
MFDS item code 201501421 · Approved 2015.03.18
This product's status changed to Approval withdrawn on 2024.12.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and continuous treatment of asthma; relief of allergic rhinitis symptoms
This medication is used to prevent and continuously treat asthma. It also helps relieve symptoms of seasonal and perennial allergic rhinitis. Therefore, it is useful for patients with asthma and allergic rhinitis to effectively manage symptoms.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue, allow it to dissolve, and take without water. To take, pour 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water immediately (within 15 minutes) and take the entire amount. Do not leave this medicine suspended in water for a long time.
Children 6~14 years of age: Chew and take 5 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. Children 2~5 years of age: Chew and take 4 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. Children 6~14 years of age: Place 5 mg of montelukast on the tongue and, once it has disintegrated, take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 2~5 years of age: Place 4 mg of montelukast on the tongue and, once it has disintegrated, take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 6~14 years of age: Place 5 mg of montelukast on the tongue, allow it to dissolve, and take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 2~5 years of age: Place 4 mg of montelukast on the tongue, allow it to dissolve, and take without water. Take this medicine 1 hour before or 2 hours after a meal. Children 6~14 years of age: Administer 5mg of montelukast orally once daily. Take this medicine 1 hour before or 2 hours after a meal. Asthma - Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Asthma - Infants 12 months~under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Asthma - Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis - Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Allergic rhinitis - Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Allergic rhinitis - Infants 6 months~under 2 years of age: Administer 4mg of this medicine orally once daily. Allergic rhinitis - Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age. The 4 mg granules of this medicine may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as weaning food, breast milk, or porridge, at or below room temperature. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix with weaning food, breast milk, or food, or take the entire amount directly. Do not leave this medicine mixed with weaning food, breast milk, or food for a long time; discard any remainder. This formulation is not designed to be mixed with beverages other than weaning food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken regardless of meal times.
This medication contains the artificial sweetener aspartame, and patients with phenylketonuria, a genetic disorder that affects phenylalanine metabolism, should avoid taking it. The daily intake of aspartame in this medication should be limited to below WHO recommended levels, with adults advised not to exceed 2.4 grams per day. Persons with known allergic reactions to this medication or any of its components should not take it, and patients with genetic disorders such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome are also prohibited from use. This medication is not intended for use during acute asthma attacks, and appropriate emergency medication should always be available in case of worsening asthma. Inhaled corticosteroids should not be abruptly discontinued or replaced with this medication; instead, they should be gradually adjusted according to a physician’s instructions. While taking this medication, psychiatric symptoms such as anxiety, depression, hallucinations, or sleep disturbances may occur; if any of these symptoms arise, you should consult a physician immediately. It should not be used alone for the treatment of exercise-induced bronchospasm, and inhaled β-agonists should continue to be used as needed. Patients with aspirin hypersensitivity should avoid taking aspirin or nonsteroidal anti-inflammatory drugs while using this medication. Do not reduce or discontinue other asthma medications unless instructed by a physician while taking this medication. If pregnant or breastfeeding, you should thoroughly discuss the necessity of this medication with your physician, considering the potential impact on the fetus or newborn. Children and elderly patients can also take this medication, but they should follow physician recommendations as safety and efficacy may vary by age. In case of overdose, there is no specific antidote; therefore, appropriate treatment and monitoring according to symptoms are necessary. This medication is sensitive to light, so the package should be opened just before taking, and it should be used immediately after preparation, keeping it out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air, moisture, and light. It is important to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness.
Pink chewable tablets that are round and convex on both sides
28 tablets (7 tablets/blister x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 5.2mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.